Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

GDC-0810

Generic Name: GDC-0810

Drug Type: Small Molecule

Chemical Formula: C_₂₆H_₂₀ClFN_₂O_₂

CAS Number: 1365888-06-7

Unique Ingredient Identifier: 9MM2R1A06R

Overview

ARN-810 has been used in trials studying the basic science and treatment of Breast Cancer.

Background

ARN-810 has been used in trials studying the basic science and treatment of Breast Cancer.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Study to Investigate the Effect of Formulation and Food on the Pharmacokinetics of GDC-0810

Phase 1

Completed

Posted: 2016/03/29

Sponsor:Genentech, Inc.

ID:NCT02722018

Effect of GDC-0810 on the Pharmacokinetics of Pravastatin in Healthy Female Subjects of Non-Childbearing Potential

Phase 1

Completed

Posted: 2015/12/04

Sponsor:Genentech, Inc.

ID:NCT02621957

A Study of GDC-0810 Versus Fulvestrant in Postmenopausal Women With Advanced or Metastatic Breast Cancer Resistant to Aromatase Inhibitor (AI) Therapy

Phase 2

Terminated

Posted: 2015/10/07

Sponsor:Genentech, Inc.

ID:NCT02569801

A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer

Phase 1

Terminated

Posted: 2013/04/04

Sponsor:Genentech, Inc.

ID:NCT01823835

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy